A Swift Solution: Early Removal of the JADA Device in the Management of Postpartum Hemorrhage

Postpartum hemorrhage (PPH) continues to be a major threat to maternal health worldwide. Current management strategies include uterotonic agents, intrauterine tamponade devices, and surgical interventions. These methods have variable efficacy, carry potential complications, and contribute to significant healthcare costs. The JADA device is an emerging and promising tool for managing PPH. We report the case of a 19-year-old G2P1011 at 39w3d who experienced uterine atony following a spontaneous vaginal delivery. Despite administration of Pitocin and tranexamic acid, the patient continued to have brisk vaginal bleeding after placental delivery. She was subsequently transferred to the OR for an exam under anesthesia due to her intolerance of pelvic examinations. Uterine atony was confirmed, and a second-degree perineal laceration with minimal bleeding was noted. The decision was made to place a JADA device when the bleeding did not resolve with uterotonics and bimanual massage. The second-degree perineal laceration was repaired in standard fashion. The JADA device was successfully removed after 30 minutes, rather than the manufacturer-recommended one-hour duration. Total quantified blood loss was 1300 mL. The patient was stable for discharge on postoperative day 2 and had an uncomplicated postoperative and postpartum course despite early removal of the JADA device. This case highlights the efficacy and safety of early JADA removal in the management of PPH. Recent data suggest that the JADA offers distinct advantages over traditional tamponade devices such as the Bakri balloon. The device’s versatility may be particularly beneficial in settings where prolonged placement is not feasible. Beyond obstetrics, the JADA device has shown potential in gynecologic procedures, such as after myomectomies. Overall, the JADA device offers a safe, effective, and versatile tool for PPH management. This case contributes to the growing evidence supporting its role in individualized care and underscores the need for further studies exploring early removal protocols.

Authors

Publication Details

Journal
Cureus
Published
2026-03-02
DOI
https://doi.org/10.7759/cureus.104570
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Swift Solution: Early Removal of the JADA Device in the Management of Postpartum Hemorrhage

Leshae A Cenac, Heather M. Wang, Alicia Huckaby
Cureus
Maternal and fetal healthcare
article

A Swift Solution: Early Removal of the JADA Device in the Management of Postpartum Hemorrhage

Leshae A Cenac, Heather M. Wang, Alicia Huckaby
article en

Abstract

Postpartum hemorrhage (PPH) continues to be a major threat to maternal health worldwide. Current management strategies include uterotonic agents, intrauterine tamponade devices, and surgical interventions. These methods have variable efficacy, carry potential complications, and contribute to significant healthcare costs. The JADA device is an emerging and promising tool for managing PPH. We report the case of a 19-year-old G2P1011 at 39w3d who experienced uterine atony following a spontaneous vaginal delivery. Despite administration of Pitocin and tranexamic acid, the patient continued to have brisk vaginal bleeding after placental delivery. She was subsequently transferred to the OR for an exam under anesthesia due to her intolerance of pelvic examinations. Uterine atony was confirmed, and a second-degree perineal laceration with minimal bleeding was noted. The decision was made to place a JADA device when the bleeding did not resolve with uterotonics and bimanual massage. The second-degree perineal laceration was repaired in standard fashion. The JADA device was successfully removed after 30 minutes, rather than the manufacturer-recommended one-hour duration. Total quantified blood loss was 1300 mL. The patient was stable for discharge on postoperative day 2 and had an uncomplicated postoperative and postpartum course despite early removal of the JADA device. This case highlights the efficacy and safety of early JADA removal in the management of PPH. Recent data suggest that the JADA offers distinct advantages over traditional tamponade devices such as the Bakri balloon. The device’s versatility may be particularly beneficial in settings where prolonged placement is not feasible. Beyond obstetrics, the JADA device has shown potential in gynecologic procedures, such as after myomectomies. Overall, the JADA device offers a safe, effective, and versatile tool for PPH management. This case contributes to the growing evidence supporting its role in individualized care and underscores the need for further studies exploring early removal protocols.

Cureus
Openalex Percentile: Top 37%
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Swift Solution: Early Removal of the JADA Device in the Management of Postpartum Hemorrhage — Leshae A Cenac, Heather M. Wang, et al. · Cureus (2026) | TGRS Research Map | TGRS